Table 2.

Risk factor analysis of coGVHD in development and validation datasets

Variables	Development dataset		Validation dataset
	OR(95% CI)	P values	OR(95% CI)	P values
LYM,10^9/L	2.26(0.95–12.48)	0.241	0.73(1.54–7.36)	0.357
PTA,%	1.19(1.07–1.46)	0.014	1.07(1.20–1.53)	0.031
CD3 + CD25 + cells,%	1.38(0.95–2.24)	0.116	0.73(1.24–2.21)	0.404
CD3 + HLA-DR + cells,%	0.95(0.88–1.00)	0.111	0.88(0.96–1.02)	0.257
OSDI	1.44(1.18–2.11)	0.009	1.52(1.16–2.72)	0.047